Search research articles
Contact Us
Filters
Showing results (291-300 of 425) with videos related to
Page
of 43
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment
Daniel P Cahill, Kymberly K Levine, Rebecca A Betensky, et al.
Cancers
|
July 12, 2025
A Review of Emerging Immunotherapeutic Strategies for IDH-Mutant Glioma
Masih Tazhibi, Eric P Grewal, Rishab Ramapriyan, et al.
Oncoimmunology
|
September 14, 2020
IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice
Leland G Richardson, Linda T Nieman, Anat O Stemmer-Rachamimov, et al.
Acta Neuropathologica Communications
|
October 22, 2020
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic
Erik A Williams, Sandro Santagata, Hiroaki Wakimoto, et al.
Behaviour Research and Therapy
|
September 13, 2022
Acceptance-enhanced behavior therapy for trichotillomania in adults: A randomized clinical trial
Douglas W Woods, Laura J Ely, Christopher C Bauer, et al.
Journal of Oncology Practice
|
January 26, 2019
Performance of a Hospital Pathway for Patients With a New Single Brain Mass
Isabel Arrillaga-Romany, William T Curry, Justin T Jordan, et al.
Neuro-Oncology
|
November 30, 2018
Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma
Tejus A Bale, Justin T Jordan, Otto Rapalino, et al.
The Journal of Clinical Psychiatry
|
June 14, 2013
Six-month follow-up of a randomized controlled trial augmenting serotonin reuptake inhibitor treatment with exposure and ritual prevention for obsessive-compulsive disorder
Edna B Foa, Helen Blair Simpson, Michael R Liebowitz, et al.
NMR in Biomedicine
|
October 5, 2021
Improving D-2-hydroxyglutarate MR spectroscopic imaging in mutant isocitrate dehydrogenase glioma patients with multiplexed RF-receive/B<sub>0</sub> -shim array coils at 3 T
Bernhard Strasser, Nicolas S Arango, Jason P Stockmann, et al.
Journal of Neuro-Oncology
|
September 13, 2018
The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study
Xiaojie Ding, Zheng Wang, Di Chen, et al.
Page
of 43
Search research articles
Search
Showing results (291-300 of 425) with videos related to
Sort By:
Page
of 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment
Daniel P Cahill, Kymberly K Levine, Rebecca A Betensky, et al.
Cancers
|
July 12, 2025
A Review of Emerging Immunotherapeutic Strategies for IDH-Mutant Glioma
Masih Tazhibi, Eric P Grewal, Rishab Ramapriyan, et al.
Oncoimmunology
|
September 14, 2020
IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice
Leland G Richardson, Linda T Nieman, Anat O Stemmer-Rachamimov, et al.
Acta Neuropathologica Communications
|
October 22, 2020
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic
Erik A Williams, Sandro Santagata, Hiroaki Wakimoto, et al.
Behaviour Research and Therapy
|
September 13, 2022
Acceptance-enhanced behavior therapy for trichotillomania in adults: A randomized clinical trial
Douglas W Woods, Laura J Ely, Christopher C Bauer, et al.
Journal of Oncology Practice
|
January 26, 2019
Performance of a Hospital Pathway for Patients With a New Single Brain Mass
Isabel Arrillaga-Romany, William T Curry, Justin T Jordan, et al.
Neuro-Oncology
|
November 30, 2018
Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma
Tejus A Bale, Justin T Jordan, Otto Rapalino, et al.
The Journal of Clinical Psychiatry
|
June 14, 2013
Six-month follow-up of a randomized controlled trial augmenting serotonin reuptake inhibitor treatment with exposure and ritual prevention for obsessive-compulsive disorder
Edna B Foa, Helen Blair Simpson, Michael R Liebowitz, et al.
NMR in Biomedicine
|
October 5, 2021
Improving D-2-hydroxyglutarate MR spectroscopic imaging in mutant isocitrate dehydrogenase glioma patients with multiplexed RF-receive/B<sub>0</sub> -shim array coils at 3 T
Bernhard Strasser, Nicolas S Arango, Jason P Stockmann, et al.
Journal of Neuro-Oncology
|
September 13, 2018
The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study
Xiaojie Ding, Zheng Wang, Di Chen, et al.
Page
of 43